Biomarker Guide

Mean Arterial Pressure (MAP): The Blood Pressure Biomarker for Pace of Aging and Longevity

Deep dive into this Longevity Biomarker's relationship with Speed of Aging and learn why it's a better indicator of Pace of Aging than Systolic or Diastolic Blood Pressure.

Scientifically Reviewed by

Dr. Olena Husak, PhD

What Is MAP?

Mean arterial pressure (MAP) is the average blood pressure in the arteries over one complete heartbeat – encompassing both the systolic (pumping) and diastolic (filling) phases[1]. Physiologically, MAP represents the steady driving pressure that ensures blood flow to vital organs.

Mean arterial pressure (MAP) is approximated by the formula MAP ≈ DBP + 1/3*(SBP – DBP), where SBP stands for Systolic Blood Pressure, and DBP - for Diastolic Blood Pressure.

The formula accounts for the fact that the heart spends more time in Diastole than Systole during the cardiac cycle.

Therefore, the MAP is not just the arithmetic mean of SBP and DBP but is weighted more toward DBP.

For example, a blood pressure of 120/80 mmHg yields a MAP around 93 mmHg.

Maintaining MAP above roughly 60–65 mmHg is critical; below this threshold, organs may not receive enough perfusion, and prolonged low MAP is linked to poor outcomes[2]. Conversely, an elevated MAP means the arteries sustain higher vascular stress with each heartbeat, which over years can injure vessel walls and strain the heart. In essence, MAP captures the balance of cardiac output and vascular resistance as a single number reflecting "average" pressure load on the circulation[1]. This makes MAP an especially useful metric for organ perfusion and overall cardiovascular strain, complementing the usual systolic and diastolic readings. Researchers even call blood pressure "the single most accessible metric of vascular aging" because long-term elevations in MAP (and related measures) contribute to wear-and-tear of the circulatory system[4].

Arterial Pressure Waveform Diagram showing systolic, diastolic, and mean arterial pressure (MAP) over the cardiac cycle.
Arterial Pressure Waveform Diagram: This diagram shows the arterial pressure over one cardiac cycle. The peak represents systolic pressure (SBP), and the lowest point shows diastolic pressure (DBP). The shaded area indicates the Mean Arterial Pressure (MAP)—the average pressure in the arteries. Since the heart spends more time in diastole, MAP is closer to DBP and is estimated by: MAP ≈ DBP + 1/3 × (SBP – DBP).

It's helpful to contrast MAP with other blood pressure measures. Systolic blood pressure (SBP) is the peak pressure when the heart contracts, while diastolic blood pressure (DBP) is the lowest pressure between beats. Pulse pressure (PP) is the difference (SBP – DBP), reflecting arterial stiffness. MAP, by comparison, is a weighted average of SBP and DBP. Unlike SBP or PP, which spike with each heartbeat, MAP changes more gradually and indicates the constant pressure driving blood flow. Clinically, MAP is often considered the most relevant pressure for ensuring organs like the brain, kidneys, and heart itself receive enough blood. For instance, coronary arteries fill during diastole, so an adequate MAP (heavily influenced by the diastolic pressure) is vital for heart muscle perfusion[3]. Thus, while SBP and DBP are vital signs, MAP provides a holistic view of hemodynamic stress. Researchers even call blood pressure "the single most accessible metric of vascular aging" because long-term elevations in MAP (and related measures) contribute to wear-and-tear of the circulatory system[4].

What Are Healthy MAP Values by Age and Sex?

In healthy adults, normal MAP typically ranges from about 70 to 100 mmHg. This corresponds to the blood pressure values considered optimal by medical societies. For instance, an ideal BP of 120/80 mmHg gives a MAP around 93 mmHg, whereas hypertension (defined by the American Heart Association as ≥130/80 mmHg) implies a MAP above ~95–100 mmHg[5][6]. Guidelines in Europe historically used a threshold of 140/90 mmHg for hypertension, which equates to a MAP near 107 mmHg[7]. In practice, a MAP in the 90s is common and generally well-tolerated in mid-life; sustained MAPs much over 100 mmHg usually indicate high blood pressure that merits attention.

Graph showing MAP trends by age and sexMean Arterial Pressure (MAP) trajectories across age for men and women. Women start lower in early adulthood but experience steeper increases in midlife, eventually surpassing men. Data adapted from longitudinal studies [4].

Age and sex strongly influence blood pressure and MAP. In early adulthood, women tend to have slightly lower MAP than men. But blood pressure rises with age in both sexes, due to arterial stiffening and other factors. Notably, women experience a steeper increase in mid-life. One large longitudinal study found that women's MAP and other BP measures start lower in their 20s but "catch up" to men's by midlife[4]. Over the life course, women's MAP actually rose faster, erasing the earlier advantage[4]. After menopause, women often surpass age-matched men in blood pressure. By the seventh decade of life, hypertension prevalence in women even exceeds that in men[8]. For example, in one U.S. analysis, 86% of women had high blood pressure by their mid-70s, versus ~80% of men[5][6]. The takeaway is that a "normal" MAP for a fit 30-year-old (perhaps ~85–90 mmHg) will drift upward with age. It's not unusual for a healthy 60-year-old to have a MAP in the mid-90s even if their blood pressure is only moderately elevated (e.g. 130/85 mmHg). Still, optimal levels remain the same – generally, MAP in the 70s to 90s – but older adults often require treatment to stay in that range.

How Is It Measured?

While systolic and diastolic blood pressure (SBP/DBP) is a usual way to represent blood pressure and widely reported by consumer wearables, the DunedinPACE algorithm—used to quantify the pace of biological aging—relies instead on Mean Arterial Pressure (MAP).

This is not a coincidence. MAP offers a more physiologically relevant measure of average arterial pressure across the entire cardiac cycle, placing greater weight on diastole, the longer phase of the heartbeat. For longevity-focused assessments, this matters: MAP correlates more robustly with long-term risks such as organ stress, vascular aging, and all-cause mortality. It is also less prone to short-term fluctuations caused by stress, movement, or environmental noise—an essential feature for use in longitudinal health modeling. From a computational perspective, MAP reduces redundancy in aging clocks by integrating SBP and DBP into a single, biologically meaningful metric. For those using wearable data to inform longevity strategies, calculating MAP adds both precision and predictive value to cardiovascular and aging risk assessments.

Basically, measuring MAP can be done in two ways: calculating it from standard blood pressure readings, or measuring it directly (intra-arterially or via arterial tonometry). In most clinical settings, MAP is calculated from the cuff blood pressure. As noted, the common formula is:

MAP calculation formula

This formula works well at normal heart rates, because diastole lasts about twice as long as systole. For example, with BP 150/90, MAP ≈ 90 + 1/3*(60) = 110 mmHg[9]. Automated blood pressure monitors often display MAP automatically using this or a more sophisticated algorithm. In critical care, MAP is measured directly by an arterial catheter – providing real-time values beat by beat. In outpatient settings, however, calculated MAP from an oscillometric cuff is sufficiently accurate for assessing cardiovascular risk[10].

What about accuracy and utility? MAP is arguably more stable than SBP, which can fluctuate with each pulse, and more informative than DBP alone. Some research suggests MAP may better predict certain outcomes like heart failure than either SBP or DBP individually[11]. Ambulatory 24-hour monitors often report MAP over the day, which captures blood pressure load on organs[12]. That said, traditional readings (SBP/DBP) and MAP are interrelated – if one is high, MAP will be high too. The advantage of MAP is in understanding perfusion: physicians managing shock or stroke pay close attention to MAP as a target (for instance, aiming for MAP ≥65 mmHg in septic shock to ensure organs aren't underperfused[2]). For everyday health monitoring, knowing your MAP can give a single-number snapshot of your overall blood pressure status. Many find it intuitive: a MAP of 100+ mmHg consistently is a red flag, while a MAP around 85–90 mmHg is generally reassuring for an adult.

MAP's Impact on Longevity

Blood pressure has a profound impact on longevity, and MAP is central to that story. Chronically elevated MAP means higher force on artery walls day in and day out – over decades this accelerates "wear and tear" on the cardiovascular system. Epidemiological studies have shown a linear relationship between blood pressure and mortality: starting from as low as 115/75 mmHg, each 20 mmHg rise in systolic (or 10 mmHg in diastolic) doubles the risk of death from heart disease or stroke[13]. This translates to roughly every ~7 mmHg increase in MAP doubling cardiovascular mortality risk in middle age. High blood pressure shortens lifespan – one analysis estimated a 50-year-old woman with hypertension lives ~4.9 years less free of cardiovascular disease than her peer with normal blood pressure[14]. In fact, hypertension (often reflected as high MAP) is associated with a shorter overall life expectancy[15]. The flip side is encouraging: maintaining optimal blood pressure is linked to longer healthspan and lifespan. Treating hypertension has been shown to significantly cut risks of heart attacks, strokes, and heart failure, thereby preserving years of life.

Interestingly, there appears to be a U-curve (or J-curve) phenomenon with MAP and mortality. Extremely high MAP is dangerous, but if MAP is too low, that can also be problematic. While we generally don't worry about low blood pressure in healthy individuals, in older or diseased populations a very low MAP may indicate frailty or poor perfusion. Large cohort studies have observed higher mortality when diastolic BP drops below ~60 mmHg[16][17]. For example, in a study of over 1.2 million adults, having a DBP <60 was associated with a 23% higher risk of all-cause death compared to DBP 70–79 mmHg[16]. This suggests that an abnormally low MAP (under ~60) might compromise blood flow to critical organs or reflect underlying illness. Thus, longevity is best supported by a Goldilocks blood pressure: not too high, but not pathologically low. Most people achieve healthy organ perfusion with MAP in the 70–90 mmHg range. Going far outside that range on either end can reduce lifespan – too high raises cardiovascular risk, too low may lead to organ under-perfusion or be a marker of serious illness.

Relationship to Chronic Diseases

Elevated MAP is a well-established risk factor for many chronic diseases of aging – especially those affecting the heart, brain, and kidneys. Cardiovascular diseases are the most direct consequence. Over time, high blood pressure causes small tears and remodeling in artery walls. The body lays down more collagen and less elastin, leading to stiffer arteries and a widening pulse pressure. This arterial stiffness further raises systolic pressures in a vicious cycle, and it forces the heart to work harder to pump blood[17][18]. The left ventricle thickens (the heart's main pumping chamber) as a coping mechanism, but eventually this can progress to heart failure. In fact, long-term studies show that about 91% of people who develop heart failure had antecedent hypertension (a history of high blood pressure before a current health event, such as a heart attack or stroke)[18]. In the Framingham Heart Study, hypertensive men had twice the risk – and hypertensive women triple the risk – of developing heart failure compared to those with normal BP[18]. By keeping MAP in check, one can significantly reduce the risk of heart failure[18].

High MAP also damages the microvasculature, the tiny vessels that nourish organs. In the brain, this can mean a greater risk of stroke and cognitive decline. Hypertension is the number one risk factor for stroke worldwide. Prolonged high MAP leads to small vessel disease in the brain – narrow, fragile arterioles that can rupture or clog. This manifests as lacunar infarcts and white matter lesions that accumulate silently, eventually contributing to stroke or vascular dementia. Long-term studies link midlife high blood pressure to a higher likelihood of dementia in later years. For instance, individuals with systolic BP ≥140 in midlife had about a 1.5-fold higher risk of developing dementia decades later[19]. A nationwide cohort in Korea found that each 10 mmHg increase in SBP raised dementia risk by ~8–22% in people under 70[20]. Consistently, those who kept their blood pressure optimally controlled had lower rates of Alzheimer's and vascular dementia[20]. The mechanism is thought to be chronic MAP elevation causing cumulative microvascular damage – essentially "wearing out" the brain's blood vessels and triggering neural injury over time. High MAP is also associated with cognitive decline independent of overt stroke, likely through reduced cerebral perfusion and microinfarcts.

In the kidneys, chronically high MAP causes high pressure inside the filtering units. The delicate filters scar over (nephrosclerosis), leading to chronic kidney disease (CKD). Hypertension is actually the second-leading cause of end-stage renal disease after diabetes[21]. About 30% of dialysis cases in the US are attributed to hypertensive kidney damage[22]. This is a two-way street: kidney disease can raise blood pressure, but hypertension itself clearly drives kidney disease progression[22]. Over years, uncontrolled MAP damages renal arteries and networks of kidney capillaries (glomeruli), reducing kidney function and causing protein to leak in the urine. Patients with longstanding high blood pressure often show a decline in glomerular filtration rate as they age, a sign that blood pressure control is crucial for preserving kidney health. On the flip side, treating hypertension aggressively can slow CKD progression and prevent kidney failure.

Other organs are not spared. Elevated MAP contributes to retinal damage (hypertensive retinopathy) in the eyes and can even affect the microcirculation in the extremities. Furthermore, high blood pressure creates a pro-inflammatory state – it's often accompanied by endothelial dysfunction, oxidative stress, and activation of hormonal pathways (like RAAS) that collectively damage tissues[23]. It's notable that many chronic diseases of aging share these pathways. That's why hypertension is sometimes called a "silent killer": it quietly causes arterial stiffness and microvascular injury that underlie heart attacks, strokes, heart failure, kidney disease, and even cognitive impairment[17][18]. Keeping MAP in a healthy range, therefore, is one of the most impactful steps to prevent age-related chronic diseases and preserve long-term health.

MAP and DNA Methylation Aging Clocks

Beyond clinical disease, elevated MAP may also accelerate biological aging, as measured by DNA methylation (epigenetic) clocks. These cutting-edge biomarkers – often called "epigenetic aging clocks" – use patterns of DNA methylation to estimate the biological age of tissues or even the pace of aging. Intriguingly, high blood pressure appears to register in these clocks, linking cardiovascular health to the epigenetic aging process. For example, the DunedinPACE clock (an epigenetic measure of the pace of aging) was developed by tracking how physiological indicators – including mean arterial pressure – change over time[24]. In fact, the Dunedin study's algorithm explicitly incorporated MAP as one of 19 biomarkers of aging (alongside things like cholesterol, HbA1c, lung function, etc.)[24]. The result is that individuals with higher MAP tend to have a faster DunedinPACE, meaning their bodies are aging quicker at the cellular level than their chronological age would predict.

There's empirical evidence connecting high blood pressure with epigenetic age acceleration. In a cohort of over 4,000 women, those with hypertension had significantly "older" DNA methylation ages than individuals with normal blood preassure – even after accounting for chronological age[25]. Specifically, having high blood pressure was associated with an epigenetic age increase corresponding to faster aging on multiple clocks (PhenoAge, GrimAge, and DunedinPACE)[25]. Women who developed hypertension over time showed that their epigenetic ages were already elevated before diagnosis, and remained higher even with treatment[25]. This suggests high MAP leaves a lasting aging signature in the body. Another analysis found that for each 1-standard deviation increase in DunedinPACE (indicating faster aging), the odds of prevalent hypertension rose ~16%[25]. In essence, elevated blood pressure is mirrored by accelerated biological aging – your arteries and tissues biologically "wear out" faster, which aging clocks like DunedinPACE can detect[25].

New multi-system aging clocks reinforce this link. SYMPHONY Age and OMICm Age are next-generation biological age measures that integrate various biomarkers (omics, clinical labs, etc.) to give a comprehensive picture of aging. These clocks capture system-specific aging (for example, cardiovascular age, metabolic age, etc.). Since MAP so strongly affects the cardiovascular system, it heavily influences these composite aging scores. While research is ongoing, preliminary data indicate that people with long-standing high MAP tend to show advanced cardiovascular aging on system-specific clocks and higher biological age on multi-omic clocks[24]. The OMICmAge clock, for instance, has been shown to correlate with chronic disease burden and mortality risk[26]– and blood pressure is a key part of that burden. By lowering your MAP into a healthy range, you're not just reducing disease risk – you may literally be slowing the ticking of your body's epigenetic clock. It's a compelling perspective: blood pressure control is not only about preventing disease, but also about slowing the biological aging process. In practical terms, someone with well-managed blood pressure is likely to have a younger "blood pressure biological age" than someone whose MAP has been high for years. This connection between MAP and longevity biomarkers underscores why controlling blood pressure is central to any longevity strategy.

How to Improve MAP (Scientifically)

Adopt the DASH Diet: The Dietary Approaches to Stop Hypertension (DASH) diet is rich in fruits, vegetables, whole grains, lean protein (especially from low-fat dairy, fish, and poultry), and nuts, while being low in saturated fat and sodium[27]. Clinical trials showed DASH has a potent blood-pressure-lowering effect. In the original DASH trial, hypertensive participants who ate the DASH combination diet (high in produce and low-fat dairy) for 8 weeks saw their blood pressure drop ~11 mmHg systolic and 5.5 mmHg diastolic more than those on a control diet[28]. Even in those without hypertension, DASH shaved off ~3 mmHg SBP compared to a standard diet[29]. By increasing potassium, magnesium, and fiber, and reducing saturated fat, DASH improves vascular function. It also emphasizes foods naturally low in salt. This dietary pattern essentially "undoes" many of the dietary contributors to high MAP.

Tip: Eat more fruits, vegetables, whole grains, and lean proteins while cutting back on salt and saturated fat. This proven diet can lower blood pressure by up to 11/5.5 mmHg in just 8 weeks.

Reduce Sodium Intake: Cutting back on salt is one of the most effective ways to lower MAP, especially if you are salt-sensitive or already hypertensive. A meta-analysis of 34 trials found that reducing salt by ~4.4 grams per day (about 1700 mg less sodium) led to an average 4.2 mmHg drop in systolic BP – and nearly 5.4 mmHg drop in those with hypertension[30][31]. The relationship is roughly linear: the more you cut sodium (within reason), the more BP falls[32]. Aim for <2.3 g of sodium per day (the FDA recommended max), or even ~1.5 g if you have high BP. Read labels, cook at home using spices and herbs instead of salt, and minimize processed foods (which are major sodium sources). Over weeks to months, your arteries will relax as excess sodium (and accompanying water) is released by the body, lowering blood volume and MAP.

Tip: Cut salt intake to <2.3g/day (or 1.5g if hypertensive). This can lower blood pressure by 4-5 mmHg in just weeks. Focus on cooking at home and avoiding processed foods.

Exercise Regularly (Aerobic and Resistance): Aerobic exercise strengthens your heart and improves arterial flexibility, which lowers MAP over time. Even moderate-intensity exercise like brisk walking, when done consistently (e.g. 150 minutes per week), can reduce systolic BP by about 3–4 mmHg and diastolic by ~2 mmHg on average[33]. Higher-intensity or longer-duration exercise often produces larger reductions. Importantly, hypertensive individuals see the biggest gains – in some studies, regular aerobic training lowered their SBP by ~5–8 mmHg. Resistance training (like weightlifting) and isometric exercises (like handgrip training) also confer benefits. One analysis found dynamic resistance training cut BP by ~4/3.8 mmHg in prehypertensives[30]. Exercise helps by improving endothelial function (the blood vessels dilate better) and by prompting weight loss and stress reduction. For longevity, combine aerobic exercise (cardio) with strength training for a one-two punch: better cardiovascular fitness and lower vascular resistance.

Tip: Aim for at least 150 minutes of moderate aerobic exercise per week, plus resistance training. Both lower blood pressure and improve heart health—especially if you have high BP.

Maintain a Healthy Weight: If you are overweight, weight loss is a powerful MAP-lowering tool. Excess body fat, especially visceral fat, raises blood pressure by increasing insulin resistance, inflammation, and activating the RAAS and sympathetic nervous system[35]. Losing even 5–10% of your body weight can yield significant BP improvements. Studies show that for each kilogram of weight lost, systolic BP drops about 1 mmHg on average. Thus, someone who loses ~10 kg (22 lbs) might expect roughly a 10 mmHg reduction in SBP[36]. Weight loss from diet and exercise synergizes with the direct effects of those interventions. It also improves sleep apnea (if present), which further benefits blood pressure. Strive for a waist circumference in the healthy range (≤102 cm for men, ≤88 cm for women) as an indicator of good metabolic health – your blood vessels will thank you[37].

Tip: Losing just 5–10% of your body weight can lower blood pressure by up to 10 mmHg. Aim for a waist circumference ≤102 cm (men) or ≤88 cm (women) for optimal vascular health.

Manage Stress (Mindfulness & Relaxation): Chronic stress is a lesser-known contributor to higher MAP. Stress triggers surges in cortisol and adrenaline, which can raise heart rate and constrict blood vessels. Over time this can lead to sustained hypertension. Mind-body interventions like meditation, deep breathing exercises, yoga, or tai chi can help lower stress-related blood pressure elevations. For example, a randomized trial in Black adults with high-normal BP found that Transcendental Meditation lowered systolic BP by ~3.3 mmHg compared to health education controls over ~20 months[38][39]. Other studies of mindfulness-based stress reduction have shown reductions on the order of 5–6 mmHg in hypertensive participants (though results vary)[40][41]. The magnitude may be modest, but in combination with other lifestyle changes, stress reduction techniques support a lower MAP. Even simple practices like daily walks in nature, journaling, or adequate leisure time help blunt the chronic sympathetic activation that drives up blood pressure.

Tip: Regular mindfulness, meditation, or relaxation practices can lower blood pressure by 3–6 mmHg. Even simple daily stress management helps support healthy MAP.

Prioritize Quality Sleep: Consistently getting enough good-quality sleep is an underappreciated way to keep MAP in check. Poor sleep (both in quantity and quality) is linked to hypertension. Short sleep duration (<6 hours per night) is associated with higher incidence of high blood pressure[42]. A recent meta-analysis of cohort studies involving over a million people found those sleeping under 5 hours had about 11% higher risk of developing hypertension compared to those getting 7–8 hours[43]. During healthy deep sleep, our blood pressure dips (a phenomenon called nocturnal dipping). Insufficient or fragmented sleep, or conditions like sleep apnea, reduce or eliminate this dip, leading to higher 24-hour MAP and greater strain on arteries. To improve sleep: keep a consistent sleep schedule, ensure a dark and quiet environment, limit caffeine and screens in the evening, and treat sleep disorders if present. In patients with obstructive sleep apnea, using CPAP (Continuous Positive Airway Pressure) at night can yield a few mmHg reduction in BP by relieving intermittent oxygen drops. Think of sleep as the nightly reset for your cardiovascular system – it's the time when heart rate and BP should decline. Supporting healthy sleep will support healthier blood pressure rhythms.

Tip: Aim for 7–8 hours of quality sleep each night. Short or poor sleep raises blood pressure and MAP—support your cardiovascular health by making sleep a priority.

Moderate Alcohol and Avoid Tobacco: Excess alcohol intake raises blood pressure. If you drink, do so moderately (no more than ~1 drink per day for women or 2 for men). Reducing heavy alcohol use can drop systolic BP by ~4 mmHg or more[43]. Smoking and tobacco use acutely raise blood pressure and chronically contribute to arterial stiffness. Quitting smoking is imperative for cardiovascular health; while it may not produce a large immediate drop in BP, it will markedly reduce the progression of arterial damage that leads to high MAP and heart disease[44].

Tip: Limit alcohol to 1 drink/day (women) or 2 (men), and avoid tobacco entirely. Both steps help lower blood pressure and protect your arteries.

In addition to lifestyle, there are supplements and emerging therapies that some evidence suggests may help. For example, increasing intake of omega-3 fatty acids (fish oil) has a mild BP-lowering effect (on the order of 2–4 mmHg SBP in some trials)[45]. Higher dietary potassium (from fruits and vegetables or supplements) can counterbalance sodium's effect – potassium helps blood vessels relax and causes the kidneys to excrete sodium. The recommended potassium intake (around 4,700 mg/day) is associated with lower BP, and supplementation has shown small reductions in BP[46]. Magnesium and calcium are also important minerals for blood pressure regulation. Emerging research is examining gut microbiome influences on blood pressure, as well as therapies like device-guided slow breathing exercises or even renal denervation for resistant hypertension[47][48]. Always discuss with a healthcare provider before starting supplements or new treatments, but know that the toolbox for optimizing MAP is growing.

Finally, when lifestyle alone isn't enough (for instance, in individuals with genetic hypertension or very high readings), medications can safely bring MAP to target. Modern antihypertensive drugs – ACE inhibitors, ARBs, calcium channel blockers, diuretics, beta-blockers, etc. – have been proven to reduce cardiovascular events and mortality by lowering blood pressure. From a longevity perspective, there is no stigma in needing medication: the goal is to get your MAP into the longevity-promoting zone. Many biohackers and preventive medicine experts emphasize lifestyle and, if required, pharmacological help to maintain optimal BP. The key is to be proactive: monitor your blood pressure (consider a home BP monitor to track your MAP), and intervene early if it's creeping up. Each 5 mmHg reduction in systolic BP (≈3 mmHg MAP) can lower risk of stroke and heart attack by ~10%[30][31]– those are huge returns for small improvements.

In summary, mean arterial pressure is a modifiable biomarker of aging. Through diet (DASH, low salt), exercise, weight control, stress reduction, sleep optimization, and appropriate therapies, you can lower your MAP and lighten the load on your arteries. It's inspiring that by doing so, you're not only improving your current well-being but actively investing in your future self – potentially extending your healthspan.

Start Measuring Your Pace of Aging Today

Track your Mean Arterial Pressure and 100+ other biomarkers of healthy aging with Liv's comprehensive health monitoring platform. Get early access to personalized insights and starting aging healthy today.

Get Early Access

Join 97 early access testers who are already tracking their pace of aging

References

  1. 1.
    Physiology, Mean Arterial Pressure
    DeMers D, Wachs D. StatPearls [Internet] 2023
  2. 2.
    Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature
    Leone M, Asfar P, Radermacher P, Vincent JL, Martin C. Crit Care 2015;19(1):101
  3. 3.
    Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg
    Li J, Somers VK, Gao X, Chen Z, Ju J, Lin Q, Mohamed EA, Karim S, Xu H, Zhang L. JAMA Network Open 2021;4(2)
  4. 4.
    Sex Differences in Blood Pressure Trajectories Over the Life Course
    Ji H, Kim A, Ebinger JE, Niiranen TJ, Claggett BL, Bairey Merz CN, Cheng S. JAMA Cardiology 2020;5(3)
  5. 5.
    Is high blood pressure inevitable? Here's how to keep it in check
    American Heart Association. Heart.org 2020
  6. 6.
    2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
    Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Bansal N, Beaton AZ, Commodore-Mensah Y, Currie ME, Elkind MSV, Fan W, Generoso G, Gibbs BB, Heard DG, Hiremath S, Johansen MC, Kazi DS, Ko D, Leppert MH, Magnani JW, Michos ED, Mussolino ME, Parikh NI, Perman SM, Rezk-Hanna M, Roth GA, Shah NS, Springer MV, St-Onge MP, Thacker EL, Urbut SM, Van Spall HGC, Voeks JH, Whelton SP, Wong ND, Wong SS, Yaffe K, Palaniappan LP; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee. Circulation 2025;151(8)
  7. 7.
    Global and European landscape of major hypertension guidelines
    McCarthy CP, Bruno RM, Rahimi K, Touyz RM, McEvoy JW. The Lancet 2024
  8. 8.
    [Epidemiology of hypertension: Differences between women and men]
    Blacher J, Kretz S, Sorbets E, Lelong H, Vallée A, Lopez-Sublet M. Presse Med 2019;48(11)
  9. 9.
    Mean arterial pressure estimated by brachial pulse wave analysis and comparison with currently used algorithms
    Grillo A, Salvi P, Furlanis G, Baldi C, Rovina M, Salvi L, Faini A, Bilo G, Fabris B, Carretta R, Benetos A, Parati G. J Hypertens 2020;38(11)
  10. 10.
    Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure
    Melgarejo JD, Yang WY, Thijs L, Li Y, Asayama K, Hansen TW, Wei FF, Kikuya M, Ohkubo T, Dolan E, et al.. Hypertension (Dallas, Tex. : 1979) 2021;77(1)
  11. 11.
    Abstract 323: Mean Arterial Pressure predicts Heart Failure Morbidity in a predominantly Minority Cohort
    Odiete O, Wariboko M, Okafor C, Nwazue V, Adebiyi O, Taylor K, Sawyer D, Okafor H. Circulation: Cardiovascular Quality and Outcomes 2012;5(suppl_1)
  12. 12.
    Ambulatory Blood Pressure Monitoring and Organ Damage
    Mancia G, Parati G. Hypertension 2000;36(5)
  13. 13.
    Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men
    Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Gaziano JM, Manson JE, Glynn RJ. Hypertension Research 2012;35(2)
  14. 14.
    Impact of salt intake on the pathogenesis and treatment of hypertension
    Shinichi Hirota, Teruo Inoue, Koichi Node. Hypertension Research 2012;35(4)
  15. 15.
    Blood Pressure in Adulthood and Life Expectancy With Cardiovascular Disease in Men and Women: Life Course Analysis
    Franco OH, Peeters A, Bonneux L, de Laet C. Hypertension 2005;46(2)
  16. 16.
    Intramuscular Injection of BOTOX® Boosts Learning and Memory in Adult Mice in Association with Enriched Circulation of Platelets and Monocytes
    Lee JS, Son ES, Lee JH, Han CS. Front Aging Neurosci 2018;9
  17. 17.
    Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Incident Cardiovascular Disease Among Koreans: A Retrospective Cohort Study with External Validation
    Lee CH, Kim K, Hyun J, et al. J Am Heart Assoc 2023;12(16)
  18. 18.
    Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry
    Hall GL, Filipow N, Ruppel G, Okitika T, Thompson B, Kirkby J, Steenbruggen I, Stanojevic S. Eur Respir J 2020;57(1)
  19. 19.
    Blood pressure from mid- to late life and risk of incident dementia
    McGrath ER, Beiser AS, DeCarli C, Plourde KL, Vasan RS, Greenberg SM, Seshadri S. Neurology 2017;89(24):2447-2454
  20. 20.
    Blood pressure and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 209 prospective studies
    Ou, Y. N., Tan, C. C., Shen, X. N., Xu, W., Hou, X. H., Dong, Q., ... & Yu, J. T.. Sci Rep 2021;11(1)
  21. 21.
    Association of respiratory symptoms and lung function with occupation in the multinational Burden of Obstructive Lung Disease (BOLD) study
    Ratanachina J, Amaral AFS, De Matteis S, Lawin H, Mortimer K, Obaseki DO, Harrabi I, Denguezli M, Wouters EFM, Janson C, Nielsen R, Gulsvik A, Cherkaski HH, Mejza F, Aanerud M, Welte T, Elsony A, Ahmed R, Nizankowska-Mogilnicka E, El Biaze M, Mahesh PA, El Rhazi K, Erhabor GE, Gislason T, Buist AS, Marks GB, Sooronbaev T, Idolor L, Wang J, Loh LC, Rashid A, Gouder C, Boehncke WR, Barbara C, Tan WC, Garcia Larsen V, Mbatchou Ngahane BH, van Zyl-Smit RN, Koul PA, Garcia-Aymerich J, Burney PGJ. Eur Respir J 2021;58(1)
  22. 22.
    High Blood Pressure and Chronic Kidney Disease
    National Kidney Foundation 2023
  23. 23.
    Significant association of estrogen and progesterone receptor protein expression with lung cancer risk in women
    Mojarad EN, Kämpjärvi K, Aavikko M, Deloger M, Tumiati M, Bellutti L, et al. Frontiers in Oncology 2023;12
  24. 24.
    Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
    Levy ML, Bacharier LB, Bateman E, Boulet LP, Brightling C, Buhl R, et al.. NPJ Prim Care Respir Med 2022;32(1)
  25. 25.
    Can DNA methylation help us understand and diagnose lung cancer?
    Leitão J, Lopes D, Costa N, Lopes F, Lopes da Costa J, Robalo Cordeiro C. Pulmonology 2023;29(3)
  26. 26.
    Ultrasensitive quantification of plasma extracellular vesicles with multiplexed droplet digital PCR reveals significant associations with common aging phenotypes
    Lu AT, Fei Z, Haghani A, et al.. Front Aging 2023;4
  27. 27.
    DASH Eating Plan
    National Heart, Lung, and Blood Institute. 2023
  28. 28.
    A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group
    Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. N Engl J Med 1997;336(16)
  29. 29.
    Respiratory risks from household air pollution in low and middle income countries
    Gordon SB, Bruce NG, Grigg J, Hibberd PL, Kurmi OP, Lam KB, Mortimer K, Asante KP, Balakrishnan K, Balmes J, Bar-Zeev N, Bates MN, Breysse PN, Buist S, Chen Z, Havens D, Jack D, Jindal S, Kan H, Mehta S, Moschovis P, Naeher L, Patel A, Perez-Padilla R, Pope D, Rylance J, Semple S, Martin WJ 2nd. Lancet Respir Med 2014;2(10)
  30. 30.
    Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritis
    Hoving JL, Lacaille D, Urquhart DM, Hannu TJ, Sluiter JK, Frings-Dresen MH. Cochrane Database Syst Rev 2014;11
  31. 31.
    Association between pulmonary function and sputum biomarkers in cystic fibrosis
    Mayer-Hamblett N, Aitken ML, Accurso FJ, Kronmal RA, Konstan MW, Burns JL, Sagel SD, Ramsey BW. Am J Respir Crit Care Med 2013;187(8)
  32. 32.
    Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials
    He FJ, Li J, Macgregor GA. BMJ 2013;346
  33. 33.
    Association between walking and cardiovascular risk factors in middle-aged women
    Lee, S. H., Ahn, J. & Kim, J. M.. Sci Rep 2023;13(1)
  34. 34.
    Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Hypertension 2003;42(6)
  35. 35.
    Renin-Angiotensin-Aldosterone System (RAAS): What It Is
    Cleveland Clinic medical professional. Cleveland Clinic Health Articles 2023
  36. 36.
    American Thoracic Society Assembly on Behavioral Science and Health Services Research 2002-2021: Impact and Evolution
    Trivedi NS, Abernathy-Close L, Applegate WB, Brown TT, Caldwell B, Casanova C. Am J Respir Crit Care Med 2003;168(6)
  37. 37.
    Should we Integrate the Gut Joint Axis into the Disease Activity Score-21 in Patients with Spondyloarthritis? A Controlled Study
    Zabotti A, Lorenzi M, Cereser L, Chiodini I, Raimondo MG, Giovannini I, Tinazzi I, Variola A, Cipriano E, Fantò M, Atzeni F, De Vita S, Di Sabatino A. J Crohns Colitis 2024
  38. 38.
    A new framework for advancing in cystic fibrosis research and treatment through identification of modified disease trajectories
    Almeshari MA, Alobaidi NY, Sapey E, Tarn J, Ahmad A, Jones AM, Webb K, Foggo V, Edgar JD, Stockley RA, Jones RB. J Cyst Fibros 2021;20(3)
  39. 39.
    Excessive weight gain after treatment of Helicobacter pylori infection
    Kim JH, Kim SH, Shin DW, Lee HS, Oh SJ, Yim E, Jung YH, Bae JM. Helicobacter 2021;26(6)
  40. 40.
    Effect and Acceptability of Mindfulness-Based Stress Reduction Program on Patients With Elevated Blood Pressure or Hypertension: A Meta-Analysis of Randomized Controlled Trials
    Lee EKP, Yeung NCY, Xu Z, Zhang D, Yu CP, Wong SYS. Hypertension 2020;76(6)
  41. 41.
    Analysis of Stress Reduction Using Mindfulness Meditation and Yoga: Results From a Randomized Controlled Trial
    Blom K, Baker B, How M, Irvine J, Perkins N, Tobe SW. Canadian Journal of Cardiology 2012;28(5):S418-S419
  42. 42.
    The association between periodontitis and hypertension with 4-year follow-up: A longitudinal study based on the National Health Insurance Service database
    Lee HY, Lee SW, Nam Y, Seo J, Jang JW, Lee SM, Kim D, Kim DI, Jhoo JH. J Periodontol 2024
  43. 43.
    Effect of Alcohol Abstinence on Blood Pressure: Assessment by 24-Hour Ambulatory Blood Pressure Monitoring
    Aguilera MT, de la Sierra A, Coca A, Estruch R, Fernández-Solá J, Urbano-Márquez A. Hypertension 1999;33(2)
  44. 44.
    Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women
    Blair SN, Kampert JB, Kohl HW 3rd, Barlow CE, Macera CA, Paffenbarger RS Jr, Gibbons LW. JAMA 1996;276(3):205-10
  45. 45.
    Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet
    Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH. N Engl J Med 2001;344(1)
  46. 46.
    Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease
    Valdivieso Á, Ribas J, Loscos E, Orozco-Levi M. PLoS One 2018;13(10)
  47. 47.
    Clinical Implications of FEV1 Decline Over One Year in Patients With Pre-COPD
    Hwang JA, Kim YS, Leem AY, Park B, Chang J, Jung JY, et al. Chest 2023;164(5)
  48. 48.
    Device-guided slow breathing with direct biofeedback of pulse wave velocity - acute effects on pulse arrival time and self-measured blood pressure
    Mengden T, Bachler M, Sehnert W, Marschall P, Wassertheurer S. Medical Signal Analysis 2023